496 Hassaneen et al.
(C O) cm−1; 1H NMR (DMSO-d6) δ 6.92 (s, 1H),
7.41–7.72 (m, 9H), 8.34 (s, 1H), 11.20 (s, 1H), 13.21
(s, 1H); MS m/z: 316, 315, 270, 185, 157, 143, 102, 77.
Anal. Calcd for C19H13N3O2: C, 72.37; H, 4.16; N,
13.33. Found: C, 72.19; H, 3.99; N, 13.05%.
Synthesis of 2-[(1,3-Diphenyl-7-amino-1,2,4-
triazolo[4,3-a]pyrimidin-5-one)methylene]-1,3-
indenedione (16)
An equimolecular amount of 15 (1.79 g, 5 mmol)
and 1,3-indene-dione (0.73 g, 5 mmol) was refluxed
in boiling ethanol (30 ml) for 2 h. The excess sol-
vent was evaporated under reduced pressure and
the residue was treated with methanol (10 ml). The
solid that formed was collected and crystallized from
dimethylformamide to give 16 in 90% yield; mp
317◦C; IR (KBr) ν 3440 (OH), 1717 (C O), 1643
(C O) cm−1; 1H NMR (DMSO-d6) δ 6.19 (s, 1H), 7.41–
8.09 (m, 14H), 8.52 (s, 1H), 11.18 (s, 1H); MS m/z:
459, 383, 355, 303, 178, 163, 91, 76.
2-[(4-Phenylpyrazol-3-ylamino)methylene]-1,3-
indenedione (18d)
The compound was obtained in 82% yield; mp 263◦C;
IR (KBr) ν 3428 (NH), 3199 (NH), 1698 (C O), 1656
1
(C O) cm−1; H NMR (DMSO-d6) δ 7.31–7.72 (m,
9H), 8.11 (s, 1H), 8.42 (s, 1H), 11.30 (s, 1H), 13.21 (s,
1H); MS m/z: 316, 315, 314, 181, 143, 102, 50.
Anal. Calcd for C19H13N3O2: C, 72.37; H, 4.16; N,
13.33. Found: C, 72.24; H, 3.94; N, 13.15%.
Anal. Calcd for C27H17N5O3: C, 70.58; H, 3.73; N,
15.24. Found: C, 70.45; H, 3.56; N, 14.98%.
2-[(Benzimidazol-2-ylamino)methylene]-1,3-
indenedione (18e)
Synthesis of 18a–e: General Method
A mixture of compound 1a or 1b (5 mmol) and one
of 17a–e (5 mmol) in ethanol (30 ml) was refluxed
for 2 h and left to cool. The solid product was col-
lected by filtration and crystallized from dimethyl-
formamide to give compounds 18a–e, respectively.
The compound was obtained in 80% yield; mp 209◦C;
IR (KBr) ν 3369 (NH), 3187 (NH), 1690 (C O), 1651
(C O) cm−1; 1H NMR (DMSO-d6) δ 6.21 (s, 2H), 6.82–
7.13 (m, 8H), 7.60 (s, 1H); MS m/z: 290, 289, 271, 243,
203, 146, 134, 86, 52.
Anal. Calcd for C17H11N3O2: C, 70.58; H, 3.83; N,
14.53. Found: C, 70.29; H, 3.62; N, 14.35%.
2-[(Triazol-5-ylamino)methylene]-1,3-
indenedione (18a)
The compound was obtained in 70% yield; mp 230◦C;
IR (KBr) ν 3325 (NH), 3201 (NH), 1665 (C O), 1643
(C O) cm−1; MS m/z: 240, 201, 186, 159, 144, 101,
75, 53.
Anal. Calcd for C12H8N4O2: C, 60.00; H, 3.36; N,
23.32. Found: C, 59.70; H, 3.06; N, 23.10%.
Synthesis of 19a–e
Method A. A mixture of compound 1a or 1b
(5 mmol) and one of 18a–e (5 mmol) in acetic acid
(30 ml) was refluxed for 4 h and left to cool. The solid
product was collected by filtration and crystallized
from dimethylformamide to give compounds 19a–e,
respectively.
2-[(3-Methylpyrazol-5-ylamino)methylene]-1,3-
indenedione (18b)
Method B. A mixture of each compound 20a–e
(5 mmol) and 1,3-indene-dione (0.73 g, 5 mmol) in
acetic acid (30 ml) was refluxed for 1 h and left to
cool. The solid product was collected by filtration and
crystallized from dimethylformamide to give com-
pounds which were identical in all respects (mp,
mmp, and spectral data) with 19a–e obtained by
Method A.
The compound was obtained in 85% yield; mp 270◦C;
IR (KBr) ν 3202 (NH), 3140 (NH), 1697 (C O), 1656
(C O) cm−1; 1H NMR (DMSO-d6) δ 2.63 (s, 3H),
6.29 (s, 1H), 7.89 (s, 4H), 8.33 (s, 1H), 11.12 (s,
1H), 12.53 (s, 1H); MS m/z: 254, 253, 225, 196, 157,
129, 101, 76, 67; 13C NMR (DMSO-d6) δ 12.49, 77.22,
95.84, 123.13, 135.69, 141.33, 142.28, 144.96, 157.02,
177.36.
Anal. Calcd for C14H11N3O2: C, 66.39; H, 4.38; N,
16.59. Found: C, 66.23; H, 4.12; N, 16.42%.
11-Hydroindeno[2,3-e]1,2,4-triazolo[1,5-a]-
pyrimidin-6-one (19a)
The compound was obtained in 77% yield; mp 281◦C;
IR (KBr) ν 1711 (C O) cm−1; MS m/z: 223, 222, 194,
167, 142, 126, 111, 91, 53.
Anal. Calcd for C12H6N4O: C, 64.86; H, 2.72; N,
25.22. Found: C, 64.65; H, 2.55, N, 24.96%.
2-[(3-Phenylpyrazol-5-ylamino)methylene]-1,3-
indenedione (18c)
The compound was obtained in 87% yield; mp 299◦C;
IR (KBr) ν 3289 (NH), 3223 (NH), 1698 (C O), 1654